Thomas Jefferson University

Jefferson Digital Commons
Department of Psychiatry and Human Behavior Department of Psychiatry and Human Behavior
Faculty Papers
6-2014

Personality and functional vision in older adults with age-related
macular degeneration
Barry W. Rovner
Thomas Jefferson University

R. J. Casten
Department of Psychiatry and Human Behavior, Jefferson Medical College

Mark T. Hegel
Departments of Psychiatry and Community and Family Medicine, The Geisel School of Medicine at
Dartmouth

Robert W. Massof
Lions
Research
andworks
Rehabilitation
Center, Wilmer Eye Institute, The Johns Hopkins University
FollowVision
this and
additional
at: https://jdc.jefferson.edu/phbfp
School of Medicine
Part of the Geriatrics Commons, and the Ophthalmology Commons

Benjamin E. Leiby

Let
us know how access to this document benefits you
Department of Pharmacology and Experimental Therapeutics, Jefferson Medical College
Recommended Citation
See next page for additional authors
Rovner, Barry W.; Casten, R. J.; Hegel, Mark T.; Massof, Robert W.; Leiby, Benjamin E.; Ho, Allen
C.; and Tasman, William S., "Personality and functional vision in older adults with age-related
macular degeneration" (2014). Department of Psychiatry and Human Behavior Faculty Papers.
Paper 20.
https://jdc.jefferson.edu/phbfp/20
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Psychiatry and Human Behavior Faculty Papers by an authorized
administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

Authors
Barry W. Rovner, R. J. Casten, Mark T. Hegel, Robert W. Massof, Benjamin E. Leiby, Allen C. Ho, and William
S. Tasman

This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/phbfp/20

Personality and Functional Vision in Older Adults with Age-Related Macular Degeneration

Barry W. Rovner
Departments of Psychiatry and Neurology,
Jefferson Medical College
barry.rovner@jefferson.edu

Robin J. Casten
Department of Psychiatry and Human Behavior,
Jefferson Medical College
robin.casten@jefferson.edu

Mark T. Hegel
Departments of Psychiatry and Community & Family Medicine
The Geisel School of Medicine at Dartmouth
Mark.T.Hegel@Dartmouth.edu

Robert W. Massof
Lions Vision Research and Rehabilitation Center
Wilmer Eye Institute
Johns Hopkins University School of Medicine
rmassof@lions.med.jhu.edu

Benjamin E. Leiby
Department of Pharmacology and Experimental Therapeutics,
Jefferson Medical College
benjamin.leiby@jefferson.edu

Allen C. Ho
Wills Eye Hospital
Department of Ophthalmology
Jefferson Medical College
acho@att.ne

William S. Tasman, MD
Wills Eye Hospital
Department of Ophthalmology
Jefferson Medical College
wst1@ureach.com

Address for correspondence and reprints:

Barry W. Rovner, MD
Jefferson Hospital for Neuroscience
900 Walnut Street, 2nd Floor
Philadelphia, PA 19107
barry.rovner@jefferson.edu
TP: 215-503-1254
FAX: 215-503-1992

Abstract

Introduction: To determine whether personality traits influence self-reported functional vision in
patients with Age-Related Macular Degeneration (AMD).

Methods: This is a prospective cross-sectional analysis of baseline data from the Low Vision
Depression Prevention Trial. Participants (N=182) over age 65 with bilateral AMD, visual
acuity worse than 20/70 in the better-seeing eye, and subthreshold depression were recruited
from the Wills Eye Hospital retina practice. Assessments included visual acuity, contrast
sensitivity, National Eye Institute Visual Function Questionnaire-25 plus Supplement (NEI
VFQ) near and distance subscales, depression, and personality testing. Structural equation
models were used to investigate the relationship of the NEI VFQ near-activities and distanceactivities with the various demographic, clinical, and psychological predictors.

Results: In the single predictor model for near functional vision, visual acuity at logMAR ≤ 1
(estimate = -0.33 [95% confidence interval (CI) -0.46, -0.20]; p ≤ 0.001), neuroticism (estimate
= - 0.05 [95% CI -0.08,-0.01]; p = 0.01), and education (estimate = -0.08 [95% CI 0.01, 0.15]; p
= 0.03) were statistically significant predictors . In the single predictor model for distance
functional vision, only visual acuity at logMAR ≤ 1 (estimate = -0.49 [95% CI -0.69, -0.29]; p ≤
0.001) and neuroticism (estimate = - 0.09 [95% CI -0.15,0.02]; p = 0.008) were statistically
significant predictors.
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Discussion: Self-reported functional vision depends on the severity of vision loss as well as the
personality trait of neuroticism.

Implications for Practitioners: Assessment of personality traits, particularly neuroticism, may
increase the precision of rating scales of functional vision and suggest new rehabilitative
interventions to improve the functional vision and quality of life of patients with AMD.

Trial Registration: clinicaltrials.gov Identifier: NCT00572039
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Introduction

Perceived functional vision refers to the self-reported ability to perform vision-dependent
activities and is often an outcome in epidemiological studies of vision loss and clinical trials of
ophthalmologic and rehabilitative treatments to improve vision and everyday functioning.
Functional vision is distinct from visual function, which more properly refers to the physiologic
activity and function of the eyes and the visual system (Colenbrander, 2005). In principle,
functional vision ought to be closely tied to objective measures of visual function but the
correlation with visual acuity, for example, ranges from 0.5 to 0.68 (Massof, 2001; Revicki,
2010). This suggests that non-ophthalmologic factors may contribute to the relationship. One of
those factors may be the characteristic way patients perceive and report difficulty in their lives.
Functional vision is assessed by asking patients to rate the difficulty they experience when
performing various activities like reading newsprint or doing housework. Their responses reflect
their perceived difficulty, the value they place on the activity, their mood, and personality.
Depressed mood is known to impair functional vision, perhaps through loss of interest, low selfefficacy, and low motivation (Casten and Rovner, 2008; Horowitz, 2005; Owsley, 2004; Rovner,
2006; Zhang, 2013). Only a few studies have evaluated the impact of personality, which shapes
an individual’s style of perceiving, responding to, and reporting visual difficulties (Boerner,
2006; Rovner, 2001; Tabrett, 2012; Warrian, 2009). In fact, personality provides a more stable
and enduring representation of a person than depression, which tends to be transient and situation
dependent (McCrae and Costa, 1990).
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One facet of personality is the trait of neuroticism, which refers to the increased tendency to
experience negative, distressing emotions (McCrae and Costa, 1990). This trait is distributed
normally in the population without a threshold indicative of disorder and is moderately heritable
(Wray, 2008). Individuals on the extreme of the distribution get upset easily by life events and
stay upset longer than others who face similar difficulties. They tend to be temperamental,
anxious, and inflexible and to hold pessimistic views of themselves and their circumstances.
Thus, given the same degree of vision loss, people high and low in neuroticism might vary
substantially in their reporting of functional vision. If their scores on the National Eye Institute
Visual Function Questionnaire (NEI-VFQ) differ, we cannot assume that the person who reports
worse functional vision (i.e., has a lower NEI VFQ score) has worse visual acuity than a person
with a higher score (Mangione, 2001). The former person may simply have a perceptual bias that
conveys greater distress and disability. The extent to which this phenomenon occurs in patients
with AMD is uncertain because no studies to our knowledge have investigated it. If the extent is
substantial it may confound the results of studies on vision loss and disability or on the efficacy
of ophthalmologic and rehabilitative treatments. In this study, we tested the hypothesis that
personality traits would influence self-ratings of functional vision independent of objective
measures of vision (i.e., visual acuity, contrast sensitivity) in older persons with bilateral agerelated macular degeneration (AMD). The subjects were enrolled in the Low VIsion Depression
Prevention TriAL (VITAL), which is a randomized controlled clinical trial that compares the
efficacy of a combined mental health and low vision rehabilitation intervention with standard
low vision rehabilitation to prevent depression.
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Methods

This study reports baseline data obtained before randomization into the VITAL clinical trial
(clinicaltrials.gov: NCT00572039). All subjects signed an informed consent form approved by
the Institutional Review Boards of Thomas Jefferson University and Wills Eye Hospital. We
recruited 182 patients with AMD from the Midatlantic Retina practice associated with the Wills
Eye Hospital in Philadelphia, Pennsylvania between October 2009 and September 2012. The
inclusion criteria were: 1) age over 65 years; 2) bilateral AMD (either neovascular (i.e., “wet”
AMD) or geographic atrophy (i.e., “dry” AMD); 3) best corrected visual acuity worse than 20/70
in the better-seeing eye; 4) more than 5 anti-vascular endothelial growth factor (VEGF)
injections if the better eye had “wet” AMD. These injections (e.g., ranibizumab) reduce the
growth of abnormal blood vessels in the macula and have greatly improved the prognosis of this
condition (Sloan and Hanrahan, 2014). In the present study, requiring patients with wet AMD to
have had more than 5 anti-VEGF injections identified those whose vision was not likely to
improve with additional anti-VEGF treatment. This was an important consideration in this
clinical trial of low vision rehabilitation.; 5) subthreshold depressive symptoms (defined as a
Patient Health Questionnaire-9 score ≥ 5 or depressed mood or anhedonia several days per week;
and 6) moderate difficulty performing a valued vision-dependent activity. The exclusion criteria
were: 1) on-going or anticipated anti-VEGF treatment; 2) current Diagnostic and Statistical
Manual (DSM) IV-defined depressive disorder; 3) uncontrolled glaucoma, diabetic retinopathy,
corneal dystrophy, or anticipated cataract surgery; 4) low vision rehabilitation within the
previous year; and 5) cognitive impairment on an abbreviated version of the Mini-Mental Status
Examination (MMblind) that omits vision-dependent items (Reischies, 1997).
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Study Measures

A research nurse with training in psychiatry and ophthalmology conducted in-home assessments
to obtain demographic data and assess the following domains at baseline.

Functional Vision: The NEI VFQ-25 plus supplement was used to measure near-vision and
distance functional vision. The NEI VFQ is a self-rated instrument that assesses difficulty with
daily activities, social functioning, general health, problems with vision, and quality of life
(Mangione, 2001). The near-vision subscale is comprised of 6 items that rate the difficulty level
of reading newsprint; doing housework or hobbies; finding something on a crowded shelf;
reading small print on a medication bottle or legal form; determining whether bills are accurate;
and performing personal hygiene tasks. The distance-vision subscale rates the difficulty of
reading street signs or the names of stores; going down steps, stairs, or curbs in dim light or at
night; going out to see movies or plays; recognizing people across a room; taking part in active
sports or other outdoor activities; and seeing and enjoying programs on TV. Subjects rated these
items on an ordinal scale from 1 (no difficulty) to 5 (stopped doing the activity because of vision
loss). If subjects stopped doing an activity for non-vision reasons the item was scored as missing
data. Previous studies have demonstrated that these subscales are responsive to low vision
rehabilitation and anti-VEGF treatment and can be used to estimate interval scales (Chang, 2007;
Marella, 2010; McKean-Cowdin, 2010; Ryan, 2008; Stelmack, 2002).

Vision Status: Best-corrected vision (with current spectacles) was assessed using the
Lighthouse Ferris-Bailey Early Treatment Diabetic Retinopathy Study chart to measure visual
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acuity and the Pelli-Robson Contrast Sensitivity chart to measure contrast sensitivity. Near and
distance visual acuities were assessed at 16 inches and 5 feet (41 cm and 1.5 m), respectively,
using back illumination. For statistical analyses, log transformations (i.e., logMAR and log
contrast) were used for visual acuity and contrast sensitivity, respectively. LogMAR refers to the
logarithm of the minimum angle of resolution, which specifies a linear scale of visual acuity, and
recognizes that increases in letter size on visual acuity charts follow a geometric progression.
Statistical analyses in logMAR units yield more precise comparisons.

Physical Health Status: The Chronic Disease Score (CDS) was used to assess the severity of
comorbid medical problems. This score is based on a weighted sum of medications taken for
chronic diseases and is a valid predictor of health care utilization, costs, and mortality (Von
Korff, 1992). Higher scores indicate worse medical status. We also used the Multilevel
Assessment Inventory Health Conditions Check List to record the presence of acute and chronic
medical conditions (Lawton, 1982).

Depression: The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression
(Kroenke, 2001). This is one of the most commonly used reliable and validated depression
assessment instruments in health care settings. It includes the 9 criteria that define the DSM-IV
diagnoses of depression and can be used as a continuous indicator of depression severity.
Symptoms are scored as the frequency of occurrence over the past two weeks on an ordinal scale
from 0 (not at all) to 3 (every day). Scores range from 0 to 27, with higher scores indicating
worse depression.
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Personality: The Revised Neuroticism, Extroversion, Openness Five Factor Inventory (NEOFFI) was used to assess the personality traits of neuroticism, conscientiousness, and openness to
experience. The NEO-FFI is a 60-item psychological personality inventory that measures these
common personality traits (Costa and McCrae, 1992). Higher scores signify higher standing on a
given trait. Extensive research substantiates the NEO’s inter-rater reliability, validity, stability
over time, and applicability across different ages, cultures, and methods of measurement
(McCrae, 2011).

Statistical Methods

Descriptive statistics for baseline demographic and clinical variables are presented as means
(SD) for continuous data and as frequencies (percentages) for categorical data. We used two
separate structural equation models to investigate the relationship of the NEI VFQ near-activities
and distance-activities subscales with the various demographic, clinical, and psychological
predictors (Moustaki, 2003; Skrondal, 2004). Because we expected subjects’ responses on the
two functional vision subscales to depend on multiple variables, our models assume that each
subject has a self-perceived ability to perform near or distance activities that is manifested by
their responses to the 6 NEI VFQ near activity items (i.e., the composite latent variable of “near
functional vision”), and the 6 NEI VFQ distance activities (i.e., the composite latent variable of
“distance functional vision”), respectively.

The structural equation model has two parts. The first part reduces the 6 observed items to a
single latent variable. The second part models the relationship between the latent variable and
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other observed covariates through a linear regression model. The value of the latent variable can
be estimated for each subject based on the model parameter estimates and the subject’s observed
NEI VFQ items and other characteristics. While the model has two parts, the parameters of both
parts are estimated simultaneously.

The main focus of the analysis was to estimate the association between the two latent variables
and the clinical and psychological predictors. The latent variable is centered on zero and is
normally distributed. After initial fitting of the latent variable model without any explanatory
variables, estimated latent variable scores were plotted against the clinical and psychological
predictors to determine whether a linear relationship could be assumed. A linear relationship
seemed reasonable for most factors except visual acuity, which had a different relationship for
acuities less than logMAR of 1.0 vs. those greater than 1.0. Consequently, a piecewise
regression model was used for visual acuity to allow for different slopes below and above
logMAR values of 1.0. We fit two sets of models. The first considered the association of near or
distance functional vision and various clinical and psychological predictors individually (single
predictor models). The second considered the association of near or distance functional vision
with the predictors simultaneously (multivariable models). The values of the latent functional
vision variables were estimated for each subject from the multivariable models. All structural
equation models were fit using Mplus version 6 (Muthe’n, 2010).
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Results

The demographic, clinical, and psychological characteristics of the 182 subjects are summarized
in Table 1. Their mean [standard deviation (SD)] age was 84.1 (6.7) years and 129 (71%) were
women. The mean near visual acuity logMAR of .66 corresponds to a Snellen visual acuity of
about 20/80. The mean neuroticism score was 20.5 (SD 6.4). This is nearly identical to the
score of 20.7 (SD 7.3) that we found in an earlier study of patients with AMD and comparable to
the average score of 19.1 (SD 7.7) in the community (Costa and McCrae, 1992; Rovner, 2001).
The correlations of neuroticism with near visual acuity, distance visual acuity, and contrast
sensitivity were all ≤ 0.10 and not significant. The correlation of the NEI VFQ -25 near and
distance subscales was 0.58; p < 0.001, indicating that these indicators of functional vision share
some variance but assess somewhat independent domains.

In the single predictor models for near functional vision, only visual acuity at logMAR ≤ 1
(estimate = -0.33 [95% confidence interval (CI) -0.46, -0.20]; p < 0.001), neuroticism (estimate
= - 0.05 [95% CI -0.08,-0.01]; p = 0.01), and education (estimate = -0.08 [95% CI 0.01, 0.15]; p
= 0.03) were statistically significant predictors . In the single predictor model for distance
functional vision, only visual acuity at logMAR ≤ 1 (estimate = -0.49 [95% CI -0.69, -0.29]; p <
0.001) and neuroticism (estimate = - 0.09 [95% CI -0.15,0.02]; p < 0.008) were statistically
significant predictors. These estimates represent the change in the latent functional vision
variable associated with a 1 unit increase in the predictor (except for visual acuity where the
change represents a 0.1 increase). Age, sex, contrast sensitivity, Chronic Disease Score, PHQ-9
score, conscientiousness, and openness were unrelated to the functional vision variables.
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Table 2 shows the results of the multivariable models for near and distance functional vision
wherein we considered the unique effect of the predictors that were significant in the single
predictor models after controlling for the effects of the other variables. Both models reveal that
visual acuity at logMAR ≤ 1 and neuroticism were independently associated with difficulty with
near and distance activities. Age was marginally associated with near activities and significantly
associated with distance activities. No other variables were associated with the ability to
perform near or distance activities after adjustment for these predictors.

The Figure shows the strong correlation of both domains of functional vision with visual acuity
at the average of all variables in the model (solid line) but also the considerable variability that
remains. There is a noticeable flattening of the relationship of the near and distance functional
vision with visual acuities after acuities of logMAR ≥ 1.0, which led to the introduction of the
piecewise regression terms in the final models. The short dash line depicts the relationship
between visual acuity and functional vision for persons who score high in neuroticism (i.e., one
standard deviation [6.4 points] above average). The long dash line depicts that relationship for
persons who score low in neuroticism (i.e., one standard deviation below average). The
comparison of the 2 lines indicate that at any given level of visual acuity, persons high in
neuroticism will report worse functional vision, and persons low in neuroticism will report better
functional vision, than the average person. A 1 SD increase in neuroticism is associated with a
decrease of 0.05 X 6.4 = 0.32 (or 0.25 SD) in the near functional vision latent variable.
Similarly, for distance functional vision, a 1 SD increase in neuroticism was associated with a
0.07 X 6.4 = 0.45 (or 0.25 SD) decrease in the latent variable.

11

Discussion

Most everyday activities require a specific level of vision to complete them successfully and
independently but whether or not someone reports difficulty when carrying them out depends on
other factors like general health, compensatory strategies, depression, cognition, and personality
(Clemons, 2006; Goldstein, 2012; Horowitz, 2005; Rees, 2009; Rovner, 2006; Rovner, 2011;
Whitson, 2012). Because personality is stable throughout the life span and shapes one’s
characteristic responses to life circumstances, knowing if someone is disposed to optimism and
resilience or pessimism and vulnerability is important. It has direct relevance when functional
vision is an outcome in a clinical trial of a new ophthalmologic treatment or rehabilitative
approach because reporting bias may obscure treatment effects. In fact, accounting for reporting
bias is relevant to treatment responses in any disease in which the relationships between the
disease, disease perception, symptom reporting, and illness behavior are complex. In clinical
practice, clinicians intuitively incorporate a patient’s personality, or reporting style, into their
formulation of the patient’s disease severity and disability but in research, where a surveyor
lacks informed knowledge of the person and the disease, discerning this relationship is more
difficult. The result is that bias is introduced systematically to the extent that persons high in
neuroticism, who report more somatic complaints and disability, are represented in population or
clinic-based samples (Costa and McCrae, 1985; Lockenhoff, 2008).

We found, as expected, that visual acuity was strongly correlated with both near and distance
functional vision. The personality trait of neuroticism was also associated with both domains of
functional vision. Studying a sample of adults with mixed visual impairment (the majority of
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whom had macular disease), Tabrett and Latham (2012) found that lower levels of neuroticism
were significantly associated with better adjustment to vision loss independent of severity of
vision loss, vision-related activity loss, and duration of vision loss. Interestingly, Warrian et al
(2008), however, found no significant correlations between neuroticism and near or distance
functional vision in patients with glaucoma, perhaps because glaucoma and AMD cause different
types of vision loss (i.e., peripheral versus central loss, respectively).

In terms of other variables we examined, we found that contrast sensitivity added no additional
explanatory value after controlling for visual acuity. Depression was also not related to
functional vision, likely because variability in depressive symptoms was limited, as we enrolled
patients with a narrow, low range of depressive symptoms (i.e., patients with severe depression
or no depression were excluded). Aside from the weak correlations with older age, no other
demographic, medical, or personality characteristics were related to functional vision after
controlling for visual acuity and neuroticism. Other studies have reached similar conclusions.
Russo et al (1997) demonstrated in a primary care population that neuroticism explained
significant variance in disability independent of demographics, medical comorbidity, and
depression. Costa and McCrae (1987) found that neuroticism was related to increased somatic
complaints but not objective signs of disease in persons with coronary artery disease.

Although our results are consistent with these studies, they must be viewed in light of this
study’s limitations. The subjects were drawn from specialty eye clinics, had specific vision and
other clinical characteristics, and had enrolled in a clinical trial to prevent depression. These
unique factors limit generalizability. The study also lacked measures of retinal pathology, other
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measures of vision (e.g., visual fields), and performance-based tests that might better
characterize the direct effects of AMD on functional vision. The strengths of the study include
the large sample size, systematic ascertainment and assessment of patients whose visual,
psychological, medical, and functional characteristics were evaluated using instruments of
known reliability and validity, and the use of structural equations to estimate an interval scale of
functional vision.

The present data suggest that the personality trait of neuroticism is related to self-reported
functional vision, and that this trait may affect the results of vision research studies and the care
of patients. For researchers who use the NEI VFQ in clinical trials, measuring neuroticism may
reduce the confounding effect of reporting bias on self-rated outcomes and identify subgroups of
patients for whom an intervention is more or less effective. For this reason, researchers may
want to consider administering the 12–item Neuroticism subscale of the NEO-FFI (which takes
only about 5 minutes to administer) to control for this factor. For low vision rehabilitative and
other clinical practitioners, encountering patients whose functional vision is worse than expected,
given the objective measures of vision (e.g., visual acuity), should prompt consideration of
nonophthalmologic factors in the genesis of the patient’s difficulty. Although we recognize that
vision loss is distressing to almost everyone, most individuals adapt relatively quickly,
compensate for impairments, and establish a new equilibrium. Persons who are high in
neuroticism, however, adapt less well and experience persistent distress and disability.
Rehabilitation specialists working with such patients might first recognize and accept, rather than
minimize or be repelled by the latters’ disproportionate emotionalism and cognitive distortions
(e.g. “I’ll never get better”), and reassure them that as they do more in rehabilitation their sense
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of self-efficacy and functional abilities will improve (Alma, 2013).

Besides requiring more

time and sensitivity, neuroticism translates to higher healthcare costs. The economic costs of
neuroticism exceed those of common mental and physical disorders, ranging from low per capita
costs for persons at the lowest level of neuroticism (< $3,000) to very high costs among those at
the highest level (>$22, 000) (Cuijpers, 2010). These higher costs are often driven by
exaggerated negative health perceptions and resulting excess medical service use but might be
mitigated with appropriate recognition and treatment.

As the population ages and the prevalence of disabling chronic diseases increases, understanding
the role of person-level factors, often ones that fall outside the traditional medical model, will
become increasingly important. This is especially true as Accountable Care Organizations begin
to provide comprehensive care to populations of people, whose perceptions of health and
disability depend as much at times on personality as on clinical factors (Lockenhoff, 2008). This
fact recommends the use of brief, validated personality screening tests to identify persons with
high levels of neuroticism. Once identified, referral to mental health treatment may be helpful.
The selective serotonin uptake inhibitor, paroxetine, appears to have a specific pharmacological
effect on neuroticism when used to treat depression, and cognitive and behavior activation
therapies may also have beneficial effects (Andrews, 1996; Tang, 2009). These promising
treatments may mitigate the negative impact of this vulnerability factor (e.g., reduce the effect of
distress on healthcare use) and may improve the functional vision of older persons with AMD.
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Figure 1. Scatterplot of Near and Distance Functional Vision versus Visual Acuity

24

25

